Lataa...
Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action
INTRODUCTION: MDD represents a significant burden worldwide, and while a number of approved treatments exist, there are high rates of treatment resistance and refractoriness. Ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist, is a novel, rapid-acting antidepressant, however the mechanism...
Tallennettuna:
| Julkaisussa: | Ment Health Clin |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
College of Psychiatric & Neurologic Pharmacists
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8120982/ https://ncbi.nlm.nih.gov/pubmed/34026396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2021.05.200 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|